 Azithromycin
"Azithromycin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis.
| Descriptor ID |
D017963
|
| MeSH Number(s) |
D02.540.576.500.992.050
|
| Concept/Terms |
Zithromax- Zithromax
- Azitrocin
- Azadose
- Ultreon
- Zitromax
|
Below are MeSH descriptors whose meaning is more general than "Azithromycin".
Below are MeSH descriptors whose meaning is more specific than "Azithromycin".
This graph shows the total number of publications written about "Azithromycin" by people in this website by year, and whether "Azithromycin" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 | | 2001 | 1 | 0 | 1 | | 2005 | 0 | 1 | 1 | | 2006 | 0 | 1 | 1 | | 2008 | 1 | 0 | 1 | | 2010 | 0 | 1 | 1 | | 2011 | 2 | 0 | 2 | | 2012 | 2 | 0 | 2 | | 2013 | 1 | 1 | 2 | | 2014 | 1 | 1 | 2 | | 2015 | 5 | 1 | 6 | | 2016 | 3 | 0 | 3 | | 2017 | 1 | 0 | 1 | | 2018 | 1 | 1 | 2 | | 2019 | 3 | 1 | 4 | | 2020 | 2 | 1 | 3 | | 2021 | 2 | 6 | 8 | | 2022 | 1 | 2 | 3 | | 2023 | 1 | 3 | 4 | | 2024 | 1 | 2 | 3 | | 2025 | 2 | 2 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Azithromycin" by people in Profiles.
-
Patterson JK, Neuwahl S, Kirsch S, Moore JL, Tita ATN, Carlo WA, Lokangaka A, Tshefu A, Mwenechanya M, Chomba E, Kavi A, Metgud MC, Goudar SS, Derman RJ, Shivkumar P, Waikar M, Patel A, Hibberd PL, Nyongesa P, Esamai F, Ekhaguere OA, Bucher S, Jessani S, Tikmani SS, Saleem S, Wylie BJ, Goldenberg RL, Billah SM, Lennox R, Haque R, Petri WA, Mazariegos M, Krebs NF, Hemingway-Foday JJ, Babineau D, Koso-Thomas M, McClure EM, Bauserman M. Cost-effectiveness of intrapartum azithromycin to prevent maternal infection, sepsis, or death in low-income and middle-income countries: a modelling analysis of data from a randomised, multicentre, placebo-controlled trial. Lancet Glob Health. 2025 Apr; 13(4):e679-e688.
-
Carlo WA, Tita ATN, Moore JL, Mwenechanya M, Chomba E, Hemingway-Foday JJ, Kavi A, Metgud MC, Goudar SS, Derman RJ, Lokangaka A, Tshefu A, Bauserman M, Patterson JK, Shivkumar P, Waikar M, Patel A, Hibberd PL, Nyongesa P, Esamai F, Ekhaguere OA, Bucher S, Jessani S, Tikmani SS, Saleem S, Goldenberg RL, Billah SM, Lennox R, Haque R, Petri W, Mazariegos M, Krebs NF, Babineau DC, McClure EM, Koso-Thomas M. Effectiveness of intrapartum azithromycin to prevent infections in planned vaginal births in low-income and middle-income countries: a post-hoc analysis of data from a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Glob Health. 2025 Apr; 13(4):e689-e697.
-
Chiu C-Y, Chastain DB, Salam ME, Sassine J, Henao-Mart?nez AF. Incidence of fidaxomicin allergy in patients with macrolide allergies: a large database analysis. Antimicrob Agents Chemother. 2025 Apr 02; 69(4):e0192424.
-
Garcia T, Florin TA, Leonard J, Shah SS, Ruddy RM, Wallihan R, Desai AP, Alter S, El-Assal O, Marzec S, Keaton M, Yun KW, Leber AL, Mejias A, Cohen DM, Ramilo O, Ambroggio L. Clinical Features and Management Strategies in Children With Mycoplasma Pneumoniae. Pediatr Emerg Care. 2025 Apr 01; 41(4):305-310.
-
Gardner RA, Ferkol TW, Davis SD, Rosenfeld M, Sagel SD, Dell SD, Milla CE, Li L, Lin FC, Sullivan KM, Zariwala MA, Knowles MR, Leigh MW. Therapies Used by Children With Primary Ciliary Dyskinesia: A Natural History Study. Pediatr Pulmonol. 2025 Jan; 60(1):e27412.
-
Yasmin H, Tanveer S, Sunder Tikmani S, Moore JL, Shakeel I, Rahim A, Lokangaka A, Tshefu A, Bauserman M, Mwenechanya M, Chomba E, Goudar SS, Kavi A, Derman RJ, Krebs NF, Figueroa L, Mazariegos M, Nyongesa P, Bucher S, Esamai F, Patel A, Waikar M, Shivkumar P, Hibberd PL, Petri WA, Billah SM, Haque R, Carlo WA, Tita A, Koso-Thomas M, Hemingway-Foday J, Saleem S, McClure EM, Goldenberg RL. Antibiotic use in infants in the 6 weeks after delivery in seven low- and middle-income countries: findings from the A-PLUS trial. Paediatr Int Child Health. 2024 Sep-Nov; 44(3-4):111-121.
-
Saleem S, Yasmin H, Moore JL, Rahim A, Shakeel I, Lokangaka A, Tshefu A, Bauserman M, Mwenechanya M, Chomba E, Goudar SS, Kavi A, Derman RJ, Krebs NF, Figueroa L, Mazariegos M, Nyongesa P, Bucher S, Esamai F, Patel A, Waikar M, Shivkumar P, Hibberd PL, Petri WA, Billah SM, Haque R, Carlo WA, Tita A, Koso-Thomas M, Hemingway-Foday J, McClure EM, Goldenberg RL. Intrapartum and postpartum antibiotic use in seven low- and middle-income countries: Findings from the A-PLUS trial. BJOG. 2025 Jan; 132(1):72-80.
-
Chao DL, Arzika AM, Abdou A, Maliki R, Karamba A, Galo N, Beidi D, Harouna N, Abarchi M, Root E, Mishra A, Lebas E, Arnold BF, Oldenburg CE, Keenan JD, Lietman TM, O'Brien KS. Distance to Health Centers and Effectiveness of Azithromycin Mass Administration for Children in Niger: A Secondary Analysis of the MORDOR Cluster Randomized Trial. JAMA Netw Open. 2023 12 01; 6(12):e2346840.
-
Wagner BD, Zemanick ET, Sagel SD, Robertson CE, Stevens MJ, Mayer-Hamblett N, Retsch-Bogart G, Ramsey BW, Harris JK. Limited effects of azithromycin on the oropharyngeal microbiome in children with CF and early pseudomonas infection. BMC Microbiol. 2023 10 27; 23(1):312.
-
Hemingway-Foday J, Tita A, Chomba E, Mwenechanya M, Mweemba T, Nolen T, Lokangaka A, Tshefu Kitoto A, Lomendje G, Hibberd PL, Patel A, Das PK, Kurhe K, Goudar SS, Kavi A, Metgud M, Saleem S, Tikmani SS, Esamai F, Nyongesa P, Sagwe A, Figueroa L, Mazariegos M, Billah SM, Haque R, Shahjahan Siraj M, Goldenberg RL, Bauserman M, Bose C, Liechty EA, Ekhaguere OA, Krebs NF, Derman R, Petri WA, Koso-Thomas M, McClure E, Carlo WA. Prevention of maternal and neonatal death/infections with a single oral dose of azithromycin in women in labour in low-income and middle-income countries (A-PLUS): a study protocol for a multinational, randomised placebo-controlled clinical trial. BMJ Open. 2023 08 30; 13(8):e068487.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|